This article is proudly sponsored by Texas Student Media!
Who Should Tenet Healthcare Acquire Next?
Tenet Healthcare (NYSE: THC) is no stranger to consolidation. With 60+ hospitals, 110+ surgical centers, and a growing outpatient footprint, they’ve already transformed themselves from a sleepy operator into one of the leanest, most EBITDA-efficient players in U.S. healthcare.
But here’s the real play: M&A.
In a world where labor costs are sticky, interest rates are volatile due to inflationary pressure, and CMS reimbursements are slow to budge, scale is the only vaccine against margin erosion.
So: Which hospital chains would be the smartest acquisitions for Tenet — today?
1. Community Health Systems (NYSE: CYH)
Why it makes sense:
- Cheap. Really cheap. Like, “you-sure-you-still-operate-hospitals?” cheap.
- Operates ~70 hospitals in non-urban markets — complementary to Tenet’s urban footprint
- Struggling under debt (~$11B) — a classic distressed consolidation target
- $CYH trades at ~0.15× revenue — Tenet could clean house operationally and extract massive synergies
Risk: Labor challenges + payer mix + integration complexity
Reward: Scale + rural diversification + upside from distressed arbitrage
2. HCA Hospitals’ Non-Core Assets (Private Sale Candidate)
Why it makes sense:
- HCA (the 800-lb gorilla) occasionally sells off lower-performing hospitals
- Tenet could cherry-pick from HCA’s disposals in secondary markets
- They’ve done it before — and Tenet knows how to turn around underperformers
Risk: Not a full acquisition — more of a tuck-in strategy
Reward: High-ROI bolt-ons without overpaying
3. ScionHealth (Private)
Why it makes sense:
- Spun out of LifePoint in 2021; 61 hospitals in underserved markets
- Private equity-owned (Apollo), which means: eventual exit is inevitable
- Big post-acute and LTAC exposure — matches Tenet’s outpatient and ambulatory growth ambitions
- Could be acquired whole or in parts
Risk: PE valuation expectations–Tenet doesn’t want to overpay
Reward: Big rural scale, outpatient synergy, rehab/post-acute optionality
4. Pipeline Health (Private, Distressed)
Why it makes sense:
- Operates hospitals in California, Illinois, and Texas
- Recently emerged from bankruptcy — balance sheet still fragile
- Tenet already has presence in these markets, so synergies are real
- Could acquire for less than replacement cost
Risk: Litigation baggage + staff turnover
Reward: Geographic leverage + distressed pricing
5. Surgery Partners (NASDAQ: SGRY) — Ambulatory Angle
Why it makes sense:
- This one’s not a hospital operator, but:
- Tenet’s real money-maker is its ambulatory surgical division
- SGRY runs 180+ outpatient centers, with strong payer mix and private equity backing–recently declined Bain’s full take-private offer, with Bain still owning around 39% of SGRY–there’s real interest out there.
- Strategic fit with Tenet’s long-term outpatient focus
- Combine this with USPI (Tenet’s ASC unit), and you have the undisputed ASC king
Risk: Premium valuation (SGRY isn’t cheap–but it isn’t horribly expensive either–just a recipient of a lot of recent institutional interest)
Reward: Market dominance, higher EBITDA margins, rate-resilient cash flow
Bottom Line
If you’re Tenet, your next acquisition move is all about expanding margin and locking in patient volume — not just beds.
That means:
- Distressed players like CYH and Pipeline are buy-low, fix-later plays
- Scion and HCA assets are cleaner bolt-ons
- And SGRY? That’s an outpatient power move
Healthcare isn’t getting cheaper. So if Tenet wants to keep winning, M&A might be the healthiest prescription of all.
DISCLAIMER: This analysis of the aforementioned stock security is in no way to be construed, understood, or seen as formal, professional, or any other form of investment advice. We are simply expressing our opinions regarding a publicly traded entity.
© 2025 MacroHint.com. All rights reserved.